Hot Pursuit     20-Dec-18
Alembic Ltd Spikes 11.14%
Alembic Ltd has added 19.29% over last one month compared to 2.28% fall in S&P BSE Healthcare index and 2.34% rise in the SENSEX

Alembic Ltd rose 11.14% today to trade at Rs 50.4. The S&P BSE Healthcare index is up 0.25% to quote at 13909.98. The index is down 2.28 % over last one month. Among the other constituents of the index, Alembic Pharmaceuticals Ltd increased 3.98% and Bliss GVS Pharma Ltd added 3% on the day. The S&P BSE Healthcare index went down 2.72 % over last one year compared to the 7.48% surge in benchmark SENSEX.

Alembic Ltd has added 19.29% over last one month compared to 2.28% fall in S&P BSE Healthcare index and 2.34% rise in the SENSEX. On the BSE, 71724 shares were traded in the counter so far compared with average daily volumes of 46702 shares in the past one month. The stock hit a record high of Rs 72 on 24 Jan 2018. The stock hit a 52-week low of Rs 35.75 on 24 Jul 2018.

Previous News
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
 ( Corporate News - 03-Oct-24   09:23 )
  Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon
 ( Market Commentary - Stock Alert 30-Sep-24   08:34 )
  Alembic Pharma’s Gujarat unit gets EIR from USFDA
 ( Hot Pursuit - 28-Sep-24   13:02 )
  Alembic Pharma gets USFDA nod for Paliperidone extended-release Tablets
 ( Hot Pursuit - 27-Sep-24   13:40 )
  Alembic Pharmaceuticals appoints Head - Technical Operations (Sterile & Oncology)
 ( Corporate News - 16-Sep-24   17:45 )
  Volumes soar at Jubilant Pharmova Ltd counter
 ( Hot Pursuit - 09-Sep-24   14:30 )
  Alembic Pharmaceuticals receives USFDA final approval for Albendazole Tablets
 ( Corporate News - 05-Sep-24   13:21 )
  Market trade with robust gains; European mkt opens lower
 ( Market Commentary - Mid-Session 26-Aug-24   13:35 )
  Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam
 ( Hot Pursuit - 26-Aug-24   09:55 )
  Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
 ( Hot Pursuit - 24-Aug-24   16:59 )
  Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
 ( Corporate News - 24-Aug-24   14:03 )
Other Stories
  Malu Paper Mills Ltd leads gainers in 'B' group
  03-Oct-24   12:15
  ITD Cementation India Ltd leads gainers in 'A' group
  03-Oct-24   12:00
  J.Kumar Infra rises on securing LoA for road project in Thane
  03-Oct-24   11:45
  Transformers and Rectifiers gains on bagging order worth Rs 565-cr
  03-Oct-24   11:16
  Volumes jump at Just Dial Ltd counter
  03-Oct-24   11:00
  Hero MotoCorp total sales spurts 19% YoY in Sep
  03-Oct-24   10:50
  Yes Bank's loan book rises to Rs 2.36 lakh crore in Q2 FY25; deposits up over 18% YoY
  03-Oct-24   10:46
  Dabur India slides on forecasting mid-single digit revenue dip in Q2 FY25
  03-Oct-24   10:46
  KRN Heat Exchanger makes stellar debut
  03-Oct-24   10:31
  Maruti Suzuki total sales rises to 1,84,727 units in Sep’24
  03-Oct-24   10:12
Back Top